LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 727

Search options

  1. Article ; Online: Re: Martin Swinton, Neethu Billy Graham Mariam, Jean Ling Tan, et al. Bladder-Sparing Treatment with Radical Dose Radiotherapy Is an Effective Alternative to Radical Cystectomy in Patients with Clinically Node-positive Nonmetastatic Bladder Cancer. J Clin Oncol. 2023;41:4406-4415.

    Seisen, Thomas / Rouprêt, Morgan / Trinh, Quoc-Dien / Bellmunt, Joaquim

    European urology

    2023  Volume 85, Issue 1, Page(s) e19–e21

    MeSH term(s) Humans ; Urinary Bladder/pathology ; Cystectomy ; Urinary Bladder Neoplasms/radiotherapy ; Urinary Bladder Neoplasms/surgery ; Urinary Bladder Neoplasms/pathology ; Patients
    Language English
    Publishing date 2023-10-19
    Publishing country Switzerland
    Document type Letter ; Comment
    ZDB-ID 193790-x
    ISSN 1873-7560 ; 1421-993X ; 0302-2838
    ISSN (online) 1873-7560 ; 1421-993X
    ISSN 0302-2838
    DOI 10.1016/j.eururo.2023.09.028
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Corrigendum to "Systematic review and meta-analysis of normal infrarenal aortic diameter in the world general population and changes in recent decades. [Eur J Vasc Endovasc Surg (2022) 64, 4-14]".

    Gené, Anna / Tello, Cristina / Gonçalves, Gabriela / Tenezaca, Xavier / Bellmunt, Sergi

    European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery

    2022  

    Language English
    Publishing date 2022-10-25
    Publishing country England
    Document type Published Erratum
    ZDB-ID 1225869-6
    ISSN 1532-2165 ; 1078-5884
    ISSN (online) 1532-2165
    ISSN 1078-5884
    DOI 10.1016/j.ejvs.2022.08.035
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Reply To Kenneth B. Yatai, Mark J. Dunning, Dennis Wang. Consensus Genomic Subtypes of Muscle-invasive Bladder Cancer: A Step in the Right Direction but Still a Long Way To Go. Eur Urol 2020;77:434-5.

    Kamoun, Aurélie / de Reyniès, Aurélien / Allory, Yves / Sjödahl, Gottfrid / Robertson, A Gordon / Seiler, Roland / Hoadley, Katherine A / Groeneveld, Clarice S / Al-Ahmadie, Hikmat / Choi, Woonyoung / Castro, Mauro A A / Fontugne, Jacqueline / Eriksson, Pontus / Mo, Qianxing / Kardos, Jordan / Zlotta, Alexandre / Hartmann, Arndt / Dinney, Colin P / Bellmunt, Joaquim /
    Powles, Thomas / Malats, Núria / Chan, Keith S / Kim, William Y / McConkey, David J / Black, Peter C / Dyrskjøt, Lars / Höglund, Mattias / Lerner, Seth P / Real, Francisco X / Radvanyi, François / Aine, Mattias / Bernard-Pierrot, Isabelle / Czerniak, Bogdan / Gibb, Ewan A / Kim, Jaegil / Kwiatkowski, David J / Lebret, Thierry / Liedberg, Fredrik / Siefker-Radtke, A Arlene / Sirab, Nanor / Taber, Ann / Weinstein, John N

    European urology

    2020  Volume 77, Issue 4, Page(s) 436–438

    MeSH term(s) Consensus ; Genomics ; Humans ; Urinary Bladder Neoplasms
    Language English
    Publishing date 2020-02-07
    Publishing country Switzerland
    Document type Editorial ; Comment
    ZDB-ID 193790-x
    ISSN 1873-7560 ; 1421-993X ; 0302-2838
    ISSN (online) 1873-7560 ; 1421-993X
    ISSN 0302-2838
    DOI 10.1016/j.eururo.2019.12.014
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Reply to D. Pouessel et al, J.B. Aragon-Ching, and B.A. Adesunloye.

    Plimack, Elizabeth R / Hoffman-Censits, Jean / Rosenberg, Jonathan E / Wong, Yu-Ning / Bellmunt, Joaquim / Choueiri, Toni K

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology

    2014  Volume 32, Issue 36, Page(s) 4171–4172

    MeSH term(s) Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Biomarkers, Tumor/analysis ; Carcinoma, Transitional Cell/chemistry ; Carcinoma, Transitional Cell/drug therapy ; Cystectomy ; Female ; Granulocyte Colony-Stimulating Factor/therapeutic use ; Humans ; Male ; Neoadjuvant Therapy/methods ; Protective Agents/therapeutic use ; Urinary Bladder Neoplasms/chemistry ; Urinary Bladder Neoplasms/drug therapy
    Chemical Substances Biomarkers, Tumor ; Protective Agents ; Granulocyte Colony-Stimulating Factor (143011-72-7)
    Language English
    Publishing date 2014-12-20
    Publishing country United States
    Document type Comment ; Letter
    ZDB-ID 604914-x
    ISSN 1527-7755 ; 0732-183X
    ISSN (online) 1527-7755
    ISSN 0732-183X
    DOI 10.1200/JCO.2014.58.5281
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Book: Bladder cancer

    Bellmunt, Joaquim

    (Hematology, oncology clinics of North America ; 29,2)

    2015  

    Author's details ed. Joaquim Bellmunt
    Series title Hematology, oncology clinics of North America ; 29,2
    Collection
    Language English
    Size xv S., S. 177 - 407 : graph. Darst., Kt.
    Publisher Elsevier
    Publishing place Philadelphia, Pa. u.a.
    Publishing country United States
    Document type Book
    HBZ-ID HT018655108
    ISBN 978-0-323-35976-4 ; 0-323-35976-0
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  6. Article ; Online: Letter to the Editor, Re: van der Heijden AG, Mengual L, Lozano JJ, Ingelmo-Torres M, Ribal MJ, Fernández PL, Oosterwijk E, Schalken JA, Alcaraz A, Witjes JA. A five-gene expression signature to predict progression in T1G3 bladder cancer. Eur J Cancer. 2016; 64:127-136.

    Orsola, Anna / Mullane, Stephanie A / Bellmunt, Joaquim

    European journal of cancer (Oxford, England : 1990)

    2016  Volume 68, Page(s) 196–197

    Language English
    Publishing date 2016-11
    Publishing country England
    Document type Letter
    ZDB-ID 82061-1
    ISSN 1879-0852 ; 0277-5379 ; 0959-8049 ; 0964-1947
    ISSN (online) 1879-0852
    ISSN 0277-5379 ; 0959-8049 ; 0964-1947
    DOI 10.1016/j.ejca.2016.09.017
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Adjuvant immunotherapy in muscle-invasive urothelial carcinoma - Author's reply.

    Bellmunt, Joaquim

    The Lancet. Oncology

    2021  Volume 22, Issue 6, Page(s) e238

    MeSH term(s) Antibodies, Monoclonal, Humanized ; Carcinoma, Transitional Cell/drug therapy ; Humans ; Immunotherapy/adverse effects ; Muscles
    Chemical Substances Antibodies, Monoclonal, Humanized ; atezolizumab (52CMI0WC3Y)
    Language English
    Publishing date 2021-06-04
    Publishing country England
    Document type Letter ; Comment
    ZDB-ID 2049730-1
    ISSN 1474-5488 ; 1470-2045
    ISSN (online) 1474-5488
    ISSN 1470-2045
    DOI 10.1016/S1470-2045(21)00298-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Book: Recommendations from the Spanish Oncology Genitourinary Group (SOGUG) for the treatment of metastatic renal cancer

    Bellmunt, J.

    (Cancer chemotherapy and pharmacology ; 63, Suppl. 1)

    2009  

    Institution Spanish Oncology Genitourinary Group
    Author's details J. Bellmunt
    Series title Cancer chemotherapy and pharmacology ; 63, Suppl. 1
    Collection
    Language English
    Size A4, S13 S.
    Publisher Springer
    Publishing place Berlin u.a.
    Publishing country Germany
    Document type Book
    HBZ-ID HT015882393
    Database Catalogue ZB MED Medicine, Health

    Kategorien

  9. Book: Optimize project: recommendations of the currently management in metastatic renal cell carcinoma

    Castellano, Daniel / Bellmunt, Joaquim

    (Cancer and metastasis reviews ; 31, Suppl. 1)

    2012  

    Author's details guest ed.: Daniel Castellano ; Joaquin Bellmunt
    Series title Cancer and metastasis reviews ; 31, Suppl. 1
    Collection
    Language English
    Size S39 S.
    Publisher Springer
    Publishing place New York, NY
    Publishing country United States
    Document type Book
    HBZ-ID HT017386171
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  10. Article: Stem-Like Signature Predicting Disease Progression in Early Stage Bladder Cancer. The Role of E2F3 and SOX4.

    Bellmunt, Joaquim

    Biomedicines

    2018  Volume 6, Issue 3

    Abstract: The rapid development of the cancer stem cells (CSC) field, together with powerful genome-wide screening techniques, have provided the basis for the development of future alternative and reliable therapies aimed at targeting tumor-initiating cell ... ...

    Abstract The rapid development of the cancer stem cells (CSC) field, together with powerful genome-wide screening techniques, have provided the basis for the development of future alternative and reliable therapies aimed at targeting tumor-initiating cell populations. Urothelial bladder cancer stem cells (BCSCs) that were identified for the first time in 2009 are heterogenous and originate from multiple cell types; including urothelial stem cells and differentiated cell types-basal, intermediate stratum and umbrella cells Some studies hypothesize that BCSCs do not necessarily arise from normal stem cells but might derive from differentiated progenies following mutational insults and acquisition of tumorigenic properties. Conversely, there is data that normal bladder tissues can generate CSCs through mutations. Prognostic risk stratification by identification of predictive markers is of major importance in the management of urothelial cell carcinoma (UCC) patients. Several stem cell markers have been linked to recurrence or progression. The CD44v8-10 to standard CD44-ratio (total ratio of all CD44 alternative splicing isoforms) in urothelial cancer has been shown to be closely associated with tumor progression and aggressiveness. ALDH1, has also been reported to be associated with BCSCs and a worse prognosis in a large number of studies. UCC include low-grade and high-grade non-muscle invasive bladder cancer (NMIBC) and high-grade muscle invasive bladder cancer (MIBC). Important genetic defects characterize the distinct pathways in each one of the stages and probably grades. As an example, amplification of chromosome 6p22 is one of the most frequent changes seen in MIBC and might act as an early event in tumor progression. Interestingly, among NMIBC there is a much higher rate of amplification in high-grade NMIBC compared to low grade NMIBC.
    Language English
    Publishing date 2018-08-02
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2720867-9
    ISSN 2227-9059
    ISSN 2227-9059
    DOI 10.3390/biomedicines6030085
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top